Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who take part in the Dutch national breast cancer screening program and received a normal mammogram result (classified as BI-RADS 1 or 2, meaning no concerning findings were detected).
- People whose breast tissue has been measured as extremely dense (category D) using a specific software tool called Quantra.
- People aged between 49 and 72 years old.
- People who live within 60 kilometres of one of the 15 hospitals taking part in the trial.
- People who do not have breast implants.
- People who are willing to allow their data to be shared as part of the trial.
- People who have not previously taken part in either the DENSE trial or the STREAM trial.
Who may not be able to join:
- People who have certain types of metal inside their body (this applies only to the MRI part of the trial and is checked by phone).
- People who have previously had an allergic reaction to the contrast dye used in the imaging procedures.
- People with poorly functioning kidneys, specifically a filtration rate below 30 ml/min (this applies only to one type of imaging called CEM, and is checked using a questionnaire and possibly a kidney function test).
- People who experience severe claustrophobia (this applies only to the MRI part of the trial).
- People who weigh more than 150 kilograms (this applies only to the MRI part of the trial).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Carla van Gils, Prof., UMC Utrecht
Phone: 0031-88-7568181
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Interval Cancer Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.